Global Market Study on Transseptal Access Systems: Transseptal Access Sheath Product Type to Lead the Global Market in Terms of Value Share


Trans Septal Access Systems Market
  • Published On : Dec-2017 |
  • Pages : 191 Pages |
  • Format :

An extensive research report titled “Transseptal Access Systems Market: Global Industry Analysis (2012 – 2016) and Forecast (2017 – 2025)” crafted by Persistence Market Research assists the reader in compiling and slating key growth strategies with a view to maintain correct growth rhythm in spite of the changing market dynamics in the present as well as in the future. Analysis on each segment of the market is included and assessment of these segments across key regions in the globe is presented in a methodical format in the report.

Reflecting the global market view in a nutshell

The research report on the global transseptal access systems market covers various trends, opportunities, developments, drivers and restraints influencing the growth of the global market. These aspects are studied across key regional markets and their intensity is assessed from which the current and future market scenario is gauged. The statistics and data supporting these predictions are arranged in an orderly manner convenient for the reader to use. All the statistics are obtained taking an unbiased view into consideration thus emphasizing on the authenticity of the research report. Moreover, deep diving in the segments along with a strong data mining process enables to sketch the possible future market direction and a complete scenario of the global transseptal access systems market with valuable acumen to offer need based solutions. The research on the global transseptal access systems market is carried out keeping a predefined purpose in mind, and involves appropriate statistical data based on a clear market definition.

Systematic research backed by a strong research methodology

Primary research and secondary research are used to glean relevant insights on the global transseptal access systems market. The research process includes several funnels of validation of the data to take the numbers to almost 100 percent accuracy. The data points associated with each segment are cross verified during every level of the research. Additionally, opinions from subject matter experts and market observers is also collated and with the help of the triangulation method, data pertaining to respective market segments is validated to radiate high precision.

In-depth four level market segmentation

By Product Type

  • Transseptal Access Sheath
  • Transseptal Access Needle

By Application

  • AF Ablation
  • MV Repair
  • LAA Occlusion

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Weighted analysis on competition scenario

The research report also includes a separate section focusing on the key players in the market. This section uncovers all the major facts about the key companies involved in the activities pertaining to the global transseptal access systems market. Their product portfolio analysis, pricing strategies, marketing strategies, promotion tactics, expansion plans, regional spread, major developments and key innovations, mergers and acquisitions, important strategies, revenue, market shares, key personnel, other key financials etc., are included in this report to present a broad idea about the activities in the market based on which next moves can be planned. The companies included in this section are those with an enormous hold on the market and studying their tactics can definitely help the upcoming players to move up the ladder accomplishing their respective milestones.

Why should you invest in this study?

  • Unbiased market intelligence
  • Global perspective assessing every possible market scenario
  • A four level market segmentation covering all angles
  • In-depth analysis on every segment across every key region as well as a global view of the individual segments along with forecast highlights for a period of eight years
  • Continuous analyst support to assist in queries related to the research study

Emergence of effective and safe alternative therapies to drive the North America transseptal access systems market growth

Atrial fibrillation (AF) patients in North America have an increased risk of stroke that is fivefold more than the normal population. This is one of the most common reasons for death among the population of North America. The standard treatment to avoid stroke in patients who are suffering from atrial fibrillation is oral anticoagulation with Vitamin K antagonists such as coumadin or warfarin. The introduction of innovative technologies such as left trial appendage occlusion therapy has benefited patients. At present Amulet and Watchman are the two devices that are approved in North America and are used for LLA therapy. However, a major constraint in using the Watchmen device is the stringent reimbursement policy that does not reimburse the Watchmen device. According to the research, AF affects more than 3 million people in the region and the number of AF cases are projected to increase between 6 and 12 million by the end of 2050. This could lead to an increasing number of LLA procedures and thus heavily cost the U.S healthcare system.

Transseptal access sheath segment is anticipated to witness highest attractiveness index over the forecast period

Transseptal access sheath dominated the global transseptal access systems market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Transseptal access sheath segment is the most attractive segment, with an attractiveness index of 1.7 over the forecast period. The transseptal access sheath segment is projected to account for more than 85% value share of the global market by 2025 end. The transseptal access needle segment is expected to be the second most lucrative segment in the global transseptal access systems market. This segment is projected to account for around 14% value share of the global market by 2025 end.

transseptal-access-system-market.jpg

Key factors fueling the growth in revenue of the global market for transseptal access systems

Private and government healthcare insurance providers facilitate the reimbursement for disease diagnosis and treatment. Reimbursement of cardiac procedures is covered by various service providers and this is expected to fuel the growth in revenue of the transseptal access systems market. In addition, the continuously evolving reimbursement scenario in the global market coupled with the availability of a mix of payers is also driving the market’s growth northward. Along with this, certain other factors such as an increased intake of tobacco and alcohol and a changing lifestyle of the people leading to a hectic life are common risk issues that can cause atrial fibrillation, which is eventually increasing the number of patients across the globe.    

The global transseptal access systems market is highly consolidated

Persistence Market Research analysis reveals that the top six companies operating in the global transseptal access systems market held around 88.8% of the global market share in 2016, while the remaining players accounted for just over 11% market share in the same year. Companies active in the global market are focusing on a robust product acquisition strategy to increase their market share and venture into new markets in emerging economies. Also, strengthening of the product portfolio by launching new products with improved characteristics through enhanced product development is a key strategy adopted by some of the leading manufacturers operating in the North America transseptal access systems market.

Company Profiles

  • Boston Scientific Corporation
  • Medtronic plc
  • Biosense Webster, Inc. (Johnson & Johnson)
  • Terumo Corporation
  • St.Jude Medical LLC (Abbott Laboratories)
  • Merit Medical Systems, Inc.
  • Baylis Medical Company, Inc.
  • Pressure Product Medical Device Manufacturing LLC 
  • Cook Medical LLC
  • Transseptal Solutions, Inc.
  • Othes.
Back To Top